108 related articles for article (PubMed ID: 9259402)
1. Ectopic activation of lymphoid high mobility group-box transcription factor TCF-1 and overexpression in colorectal cancer cells.
Mayer K; Hieronymus T; Castrop J; Clevers H; Ballhausen WG
Int J Cancer; 1997 Aug; 72(4):625-30. PubMed ID: 9259402
[TBL] [Abstract][Full Text] [Related]
2. Lymphoid enhancer factor/T cell factor expression in colorectal cancer.
Waterman ML
Cancer Metastasis Rev; 2004; 23(1-2):41-52. PubMed ID: 15000148
[TBL] [Abstract][Full Text] [Related]
3. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
Schmidt M; Patterson M; Farrell E; Münsterberg A
Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
[TBL] [Abstract][Full Text] [Related]
4. HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription.
Ghogomu SM; van Venrooy S; Ritthaler M; Wedlich D; Gradl D
J Biol Chem; 2006 Jan; 281(3):1755-64. PubMed ID: 16291758
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
6. The human high mobility group (HMG)-box transcription factor TCF-1: novel isoforms due to alternative splicing and usage of a new exon IXA.
Mayer K; Wolff E; Clevers H; Ballhausen WG
Biochim Biophys Acta; 1995 Aug; 1263(2):169-72. PubMed ID: 7640309
[TBL] [Abstract][Full Text] [Related]
7. Diverse LEF/TCF Expression in Human Colorectal Cancer Correlates with Altered Wnt-Regulated Transcriptome in a Meta-Analysis of Patient Biopsies.
Mayer CD; Giclais SM; Alsehly F; Hoppler S
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403323
[TBL] [Abstract][Full Text] [Related]
8. Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties.
Van de Wetering M; Castrop J; Korinek V; Clevers H
Mol Cell Biol; 1996 Mar; 16(3):745-52. PubMed ID: 8622675
[TBL] [Abstract][Full Text] [Related]
9. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing.
Hovanes K; Li TW; Waterman ML
Nucleic Acids Res; 2000 May; 28(9):1994-2003. PubMed ID: 10756202
[TBL] [Abstract][Full Text] [Related]
10. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex.
Idogawa M; Yamada T; Honda K; Sato S; Imai K; Hirohashi S
Gastroenterology; 2005 Jun; 128(7):1919-36. PubMed ID: 15940627
[TBL] [Abstract][Full Text] [Related]
12. Tcf/Lef transcription factors during T-cell development: unique and overlapping functions.
Staal FJ; Clevers H
Hematol J; 2000; 1(1):3-6. PubMed ID: 11920163
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis.
Oosterwegel M; van de Wetering M; Timmerman J; Kruisbeek A; Destree O; Meijlink F; Clevers H
Development; 1993 Jun; 118(2):439-48. PubMed ID: 8223271
[TBL] [Abstract][Full Text] [Related]
14. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter.
Vadlamudi U; Espinoza HM; Ganga M; Martin DM; Liu X; Engelhardt JF; Amendt BA
J Cell Sci; 2005 Mar; 118(Pt 6):1129-37. PubMed ID: 15728254
[TBL] [Abstract][Full Text] [Related]
15. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
16. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
Labbé E; Letamendia A; Attisano L
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
[TBL] [Abstract][Full Text] [Related]
17. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells.
Hawcroft G; D'Amico M; Albanese C; Markham AF; Pestell RG; Hull MA
Carcinogenesis; 2002 Jan; 23(1):107-14. PubMed ID: 11756231
[TBL] [Abstract][Full Text] [Related]
20. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
